Miriam Rosás-Umbert

6PUBLICATIONS
62CO-AUTHORS
Innate immunityGene and molecular therapyMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 03, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control.

Katie Fisher, Mauro A Garcia, Giacomo S Frattari

|Mar 28, 2024
Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses.

Alex Olvera, Luis Romero-Martin, Bruna Oriol-Tordera

|Sep 11, 2023
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial.

Jesper D Gunst, Jesper F Højen, Marie H Pahus

|Oct 30, 2022
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity.

Miriam Rosás-Umbert, Jesper D Gunst, Marie H Pahus

|Oct 27, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial.

Lucia Bailón, Anuska Llano, Samandhy Cedeño

|Oct 17, 2022
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.

Jesper D Gunst, Marie H Pahus, Miriam Rosás-Umbert

Pageof 1

Frequent Collaborators

4 joint publications

Jesper D Gunst

4 joint publications

Ole S Søgaard

4 joint publications

R Brad Jones

4 joint publications

Michel C Nussenzweig